Nirmatrelvir+ritonavirLack of efficacy and off-label use

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2002卷 / 1期

关键词：

D O I：

10.1007/s40278-024-55752-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：375 / 375

相关论文

共 50 条

[1] Nirmatrelvir+ritonavirLack of efficacy, off-label and drug exposure in pregnancy
Reactions Weekly, 2024, 2002 (1) : 376 - 376
[2] Immune-globulin/methylprednisolone/nirmatrelvir+ritonavirLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1953 (1) : 210 - 210
[3] COVID-19-vaccine/nirmatrelvir+ritonavirLack of efficacy and drug eruption during off-label use: case report
Reactions Weekly, 2023, 1941 (1) : 154 - 154
[4] Nirmatrelvir+ritonavirLack of efficacy: case report
Reactions Weekly, 2023, 1965 (1) : 383 - 383
[5] Lopinavir/ritonavirLack of efficacy and off-label use
Reactions Weekly, 2024, 2003 (1) : 518 - 518
[6] Lopinavir/ritonavirLack of efficacy following off-label use: 2 case reports
Reactions Weekly, 2022, 1903 (1) : 225 - 225
[7] Hydroxychloroquine/lopinavir/ritonavirLack of efficacy following off-label use: case report
Reactions Weekly, 2022, 1908 (1) : 275 - 275
[8] Nirmatrelvir+ritonavirSevere gastrointestinal symptoms and lack of efficacy following off-label use
Reactions Weekly, 2024, 2002 (1) : 377 - 377
[9] SevofluraneLack of efficacy and off-label use
Reactions Weekly, 2024, 2012 (1) : 324 - 324
[10] EmapalumabLack of efficacy and off-label use
Reactions Weekly, 2024, 2004 (1) : 185 - 185

← 1 2 3 4 5 →